Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Change in Accured Expenses: 2010-2017

Historic Change in Accured Expenses for Tenax Therapeutics (TENX) over the last 7 years, with Dec 2017 value amounting to $172,693.

  • Tenax Therapeutics' Change in Accured Expenses fell 85.92% to $172,693 in Q4 2017 from the same period last year, while for Dec 2017 it was -$5.0 million, marking a year-over-year decrease of 363.63%. This contributed to the annual value of $523,000 for FY2024, which is 120.68% up from last year.
  • As of Q4 2017, Tenax Therapeutics' Change in Accured Expenses stood at $172,693, which was up 113.20% from -$1.3 million recorded in Q3 2017.
  • In the past 5 years, Tenax Therapeutics' Change in Accured Expenses ranged from a high of $2.1 million in Q1 2013 and a low of -$2.9 million during Q2 2017.
  • Its 3-year average for Change in Accured Expenses is -$314,403, with a median of -$820,335 in 2015.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first skyrocketed by 6,478.68% in 2013, then slumped by 1,683.32% in 2015.
  • Quarterly analysis of 5 years shows Tenax Therapeutics' Change in Accured Expenses stood at $1.3 million in 2013, then skyrocketed by 32.39% to $1.8 million in 2014, then crashed by 1,683.32% to -$1.2 million in 2015, then reached $1.2 million in 2016, then tumbled by 85.92% to $172,693 in 2017.
  • Its Change in Accured Expenses was $172,693 in Q4 2017, compared to -$1.3 million in Q3 2017 and -$2.9 million in Q2 2017.